大熊制药
A mostrar 49–64 de 65 resultados
-
ENASIDX Enasidenib 50mg
On August 1, 2017, the U.S. FDA approved entasidipine for marketing, making it the firs…Escolher opcao This product has multiple variants. The options may be chosen on the product page -
SODADX Sofosbuvir/Velpatasvir 400/100mg
SODADX is a fixed-dose combination of sofosbuvir (an HCV nucleotide analog NS5B polymer…Escolher opcao This product has multiple variants. The options may be chosen on the product page -
MITODX Mitotane 500mg
Mitotane, also known as phenylthiourea or totimarin (O,P'-DDD), is a drug used to treat…Escolher opcao This product has multiple variants. The options may be chosen on the product page -
LORLADX Lorlatinib
Lorlatinib is a third-generation drug for the treatment of non-small cell lung cancer (…Escolher opcao This product has multiple variants. The options may be chosen on the product page -
OLADX Olaparib
Olaparib is a poly(ADP-polysaccharide) polymerase (PARP) inhibitor that was approved by…Escolher opcao This product has multiple variants. The options may be chosen on the product page -
TEPODX Tepotinib
Terpotinib is an oral c-MET inhibitor designed to inhibit oncogenic MET receptor signal…Escolher opcao This product has multiple variants. The options may be chosen on the product page -
LARODX Larotrectinib
Larotrectinib is a potent, oral, selective tropomyosin receptor kinase (TRK) inhibitor …Escolher opcao This product has multiple variants. The options may be chosen on the product page -
SEMEDX Selumetinib
Selumetinib is indicated for children aged 2 years and older with neurofibromatosis typ…Escolher opcao This product has multiple variants. The options may be chosen on the product page -
ELTROMDX Eltrombopag 50mg
Eltrombopag is a thrombopoietin receptor agonist that works by inducing the differentia…Escolher opcao This product has multiple variants. The options may be chosen on the product page -
DABRADX Dabrafenib 75mg
Dabrafenib is a BRAF inhibitor cancer drug, available as a mesylate. On May 29, 2013, t…Escolher opcao This product has multiple variants. The options may be chosen on the product page -
AVATODX Avatrombopag 20mg
Avatrobappa is a targeted therapy. Targeted therapy is the result of years of research …Escolher opcao This product has multiple variants. The options may be chosen on the product page -
APADX Apalutamide
Apalutamide is a new generation of orally administered androgen receptor (AR) inhibitor…Escolher opcao This product has multiple variants. The options may be chosen on the product page -
DUVACIDX Deucravacitinib 6mg
Deucravacitinib is a novel drug used to treat autoimmune diseases. Autoimmune diseases …Escolher opcao This product has multiple variants. The options may be chosen on the product page -
UPADX Upadacitinib 15mg
Upatinib is an oral, once-daily, selective, reversible JAK inhibitor that has played a …Escolher opcao This product has multiple variants. The options may be chosen on the product page -
VECLADX Venetoclax 100mg
Venetoclax is a world-first selective drug that targets the B-cell lymphoma-2 (BCL-2) p…Escolher opcao This product has multiple variants. The options may be chosen on the product page -
ENASIDX Enasidenib 100mg
On August 1, 2017, the U.S. FDA approved entasidipine for marketing, making it the firs…Escolher opcao This product has multiple variants. The options may be chosen on the product page
